Bulbospongiosus Muscle Injection for Premature Ejaculation

Premature Ejaculation — Advanced Interventions

Bulbospongiosus Muscle Injection for Premature Ejaculation

Bulbospongiosus muscle injection is a targeted neuromuscular intervention for premature ejaculation that addresses the ejaculatory reflex at its muscular output — a newer approach for men who have not responded adequately to behavioral, pharmacological, or topical treatments.

The Role of the Bulbospongiosus Muscle in Ejaculation

Ejaculation is a two-phase spinal reflex: emission (semen moved into the posterior urethra by smooth muscle contraction) followed by expulsion (rhythmic contractions of the bulbospongiosus and ischiocavernosus muscles that propel semen out). The bulbospongiosus (BS) muscle wraps around the base of the penis and bulb of the urethra; its involuntary contractions during ejaculation are the final mechanical event that produces expulsion.

In men with premature ejaculation, the threshold at which the ejaculatory reflex triggers is low — the entire cascade initiates and completes faster than the man can voluntarily regulate. While most PE treatments target the sensory input (topical anesthetics), the central threshold (SSRIs, dapoxetine), or behavioral control (stop-start, squeeze techniques), bulbospongiosus muscle injection targets the muscular output directly, reducing the contractile force and coordination of the expulsion phase.

How the Procedure Works

Bulbospongiosus muscle injection typically uses botulinum toxin type A (Botox or equivalent) to temporarily inhibit the neuromuscular junctions in the BS muscle. Botulinum toxin prevents the release of acetylcholine at the motor nerve terminal, reducing muscle contractility. When applied to the bulbospongiosus, this reduces the force and may reduce the coordination of the expulsion contractions, increasing the time from arousal to ejaculation.

The injection is performed under office-based local anesthesia, typically guided by palpation or ultrasound to accurately target the bulbospongiosus muscle at the perineum. The procedure takes approximately 15–30 minutes. Effects typically onset over 1–2 weeks as the botulinum toxin takes effect at the neuromuscular junction and last approximately 3–6 months, after which the procedure can be repeated.

What the Evidence Shows

Bulbospongiosus muscle injection for PE is an emerging treatment with a limited but growing clinical literature. Early case series and small clinical studies have reported significant improvements in intravaginal ejaculatory latency time (IELT) and patient-reported ejaculatory control following the procedure. Some studies have reported mean IELT increases of 3–5x over baseline in responsive patients.

Honest bottom line: This is a newer intervention with promising early data but without the large randomized controlled trial evidence that supports first-line PE treatments like dapoxetine, SSRIs, or topical anesthetics. It represents a reasonable option for men who have failed or cannot use those treatments, managed by a provider with expertise in perineal anatomy and injection technique.

The procedure is not widely standardized — injection sites, dosage, and guidance methods vary across published reports. As experience accumulates and protocols become more standardized, the evidence base will strengthen. Current evidence is sufficient to offer it as an option in experienced hands, particularly for treatment-refractory PE.

Who Is a Candidate?

  • Men with lifelong or acquired PE who have not responded adequately to behavioral therapy, SSRIs, dapoxetine, or topical anesthetics
  • Men who cannot or choose not to use pharmacological PE treatments due to side effects, contraindications, or preference
  • Men with comorbid pelvic floor hypertonicity where BS muscle overactivity may be contributing to both PE and other pelvic symptoms
  • Men seeking a treatment with duration of several months rather than on-demand dosing

Botulinum toxin injection is contraindicated in men with known hypersensitivity to botulinum toxin products, neuromuscular junction disorders (myasthenia gravis, Lambert-Eaton syndrome), or active infection at the injection site. A thorough evaluation including history of PE severity, prior treatments attempted, and sexual function assessment is appropriate before proceeding.

What to Expect

The procedure itself is well tolerated with local anesthesia. Some men experience mild perineal soreness for a few days following injection. The onset of effect is gradual as the toxin takes hold over 1–2 weeks, so an assessment of response at 2–4 weeks after the procedure is appropriate before drawing conclusions.

Response is variable. Some men experience dramatic improvement in ejaculatory control; others have more modest benefit. Ejaculatory force is typically reduced, which some men find unexpected; this is an inherent part of the mechanism. If the response is insufficient, dose adjustment or combination with other treatments can be considered at subsequent sessions.

Risks and Considerations

The most common concern is over-treatment: excessive inhibition of the BS muscle can produce reduced ejaculatory force (which some men find bothersome), delayed or incomplete ejaculation, or in rare cases temporary difficulty with ejaculation. These effects resolve as the toxin wears off over 3–6 months.

Accurate injection placement is critical: the BS muscle at the perineum is adjacent to the urethra and the superficial perineal neurovascular structures. Ultrasound guidance, when used, reduces the risk of off-target injection. Post-procedure urinary symptoms (hesitancy, weak stream) are uncommon but can occur with inadvertent involvement of peri-urethral structures; these are typically temporary.

As with any botulinum toxin procedure, immunogenicity is a theoretical long-term concern with repeated injections, though it is rarely clinically significant at the doses used in this application.

Discuss Advanced PE Treatment Options

A men’s health specialist can evaluate your history and determine whether bulbospongiosus injection or another advanced approach is appropriate for your situation.

Find a Provider
Patient Reviews

Share Your Experience

Your review helps other patients make informed decisions about their care.

What Patients Are Saying

There are no reviews yet. Be the first one to write one.